From psychedelic medicine and nuclear energy to fintech, telecoms and the future of retail, the infinitas capital Frontier Summit offered a snapshot of where some of the biggest opportunities are emerging. Together with @C_Angermayer, we backed @ataibeckley long before psychedelic medicine was taken seriously by mainstream investors. Fast forward to 2026 and @EliLillyandCo agreed to acquire the business in a deal worth up to $3.8 billion. That is what backing a conviction early can look like. @chrismaurX , who helped build @Roivant into a $30 billion biotech company, spoke about why nuclear energy has become one of the most important pieces of the AI build-out, and why power will decide who wins in AI. Taig Khris won three world championships in vert skating and jumped from the Eiffel Tower before founding Onoff, which is now taking on the large telecom incumbents. We also heard from Josiah Senu (Zuba) and Alexis Vincent (K42), who are building new financial infrastructure for global businesses and retail. The next generation of category-defining companies will be built by people who are slightly unreasonable about what is possible. That is my kind of crowd.

We have had a strong start to our Frontier Summit being held in East Sussex, UK. Big ideas, ambitious founders, and conversations about whats coming next. The setting, a Georgian country house surrounded by woodland, is hard to beat. We have filled it with some of the most interesting people in tech, science and finance. @InfinitasCap is always looking for those who see opportunities where others see problems. People prepared to challenge established industries and build things that have not existed before. Yesterday was a good reminder of why getting the right people in the same room matters. Looking forward to day two.

I believe that the next generation of family offices will be far more entrepreneurial, collaborative, and open to back new ideas. It was great speaking with @PictetGroup Wealth Management about how we have built @InfinitasCap , our investment philosophy, and why I think family offices have a very exciting future ahead. Many thanks to the Pictet team for the feature pictet.com/uk/en/insights/re…

We believe that European family offices have an important role to play in backing European defence companies. Family offices can make investment decisions quickly, take a long-term view and provide ambitious entrepreneurs with the capital they need to build. Europe has extraordinary engineering talent and technological capabilities. We should be investing in them to ensure that our continent has the means to defend itself, and determine its own future. There are few more worthwhile investments than those that help protect our security and our freedom. Europes sovereignty is worth investing in.

I have been following fascinating developments in drug discovery, particularly around psychedelics and compounds that have been used by humans for a long time. What interests me is how science is now revisiting that which has long been overlooked by mainstream medicine. Psychedelics are a particularly interesting example. They are now attracting serious scientific research, pharmaceutical investment and institutional interest. I suspect we are only scratching the surface.

We are living through the next industrial revolution. I am seeing more exciting deals than ever in energy, infrastructure, #AI and neurotech, basically everything that drives the development of our world and society.

See this trend in the psychedelic industry at this point too against their 52-week highs: $DFTX: -34% down $CMPS: -30% down $HELP: -30% down $GHRS: -40% down Compass in particular is three months away from potentially having the first classic psychedelic approved by the FDA but the company is barely valued at half of what Eli Lilly paid for ATAI (while purchasing assets years away from a PH3 readout). Nothing about fundamentals justifies its current valuation. Lots of great deals right now for those wanting to enter the space.

What a week! Best way to finish.

Read this interesting article in the @FT , which highlights an opportunity for financial engineering. Financial engineering sometimes gets a bad reputation, but it can be an incredibly effective way to unlock value in a business. Rethinking capital structures, making better use of assets and freeing up capital for growth can be just as important as improving operations. The question for me is usually to see what value could be created, by looking at a business through a different financial lens. Sometimes the opportunity is not to reinvent the business, but to rethink how it is financed and structured. lnkd.in/etcrihKM

Really enjoyed this conversation between @patrick_oshag and @hubermanlab The brain is humanity’s final frontier. We understand more about Mars than about the organ that makes us who we are. That is about to change. Within a few years, the most important AI companies will be neurotech companies. Most investors haven’t realised this yet. Worth every minute: piped.video/watch?v=_QSX3BF9…

I am in the UK this week ahead of the @InfinitasCap Frontier Summit 2026, taking place next week in East Sussex. Also great to be catching up with @anilkseth , Professor of Cognitive and Computational Neuroscience at the @SussexUni , whose work is challenging how we understand consciousness and the human brain. Looking forward to introducing Anil at the summit next week, where we will be exploring interesting developments at the intersection of science, technology and investment.

Back in London for two weeks - looking forward to many interesting discussions!

Can AI ever be conscious? In two weeks I will put that question to one of the most important neuroscientists working on consciousness today. We will talk about how the brain creates the world we experience, why intelligence and consciousness may be two very different things, and whether conscious AI is something we should even want.

💯💪🏼

#AI does not run on chips alone. It runs on electricity, and electricity is becoming the constraint. The US has made its choice. The stated goal is to quadruple nuclear capacity to 400 GW by 2050. The Department of Energy has offered up to $17.5bn in loans for new reactors and is financing upgrades to existing plants that were headed for retirement only a few years ago. The opportunity goes well beyond building new reactors. It runs through the entire chain: extending and upgrading the existing fleet, rebuilding supply chains, training a new generation of engineers, and developing new technologies that make nuclear faster and cheaper to deploy. These are engineering and entrepreneurial problems, not only policy problems. A new generation of founders is working on them now. Europe should pay close attention. To compete in AI and energy-intensive industry, we need clean, reliable and affordable power at a scale we do not have today. @InfinitasCap , this is one of the areas we spend most of our time on.

When @ScottNolan , an early @SpaceX employee and partner at @peterthiel's @foundersfund, started looking into nuclear, advanced reactor companies kept telling him that their biggest obstacle was not regulation or technology. It was access to fuel. We spend a lot of time talking about new reactors, and far less about the infrastructure and supply chains they depend on. @generalmatter is taking on uranium enrichment, a less visible part of the industry, but one that could determine how quickly a new generation of nuclear capacity becomes a reality. It is also why we have been looking beyond the reactors themselves, at the businesses solving the bottlenecks that could otherwise hold the industry back. For an investor, understanding what could constrain growth is often a good place to start. politico.com/news/2026/09/27…

Monday thought. We spend a lot of time talking about AI models. Much less about how we are going to power them. The IEA expects electricity demand from data centres to roughly double by 2030. A new model can be trained in a few months. A new power plant takes years to build. IMO this is the real bottleneck for AI, and it is where a lot of value will be created over the next decade. We are currently working on two investments in energy, more on them soon. Both are based on the same belief: without far more clean and reliable energy, the #AI story doesnt work. Wishing everyone a great week.

Spending time in Stockholm last week was a strong reminder of why we keep coming back to Sweden. Swedish households now have more wealth in equities than property. Retail participation is deep, smaller listed companies actually receive attention, and there is a much more natural relationship between venture capital and public markets. That matters when so many European VCs are sitting on good companies but struggling to find exits. We dont think the answer is simply to wait for the traditional IPO market to come back. Part of what we are building at @InfinitasCap and @reverioncapital is a route for good European growth companies to access the capital and liquidity that already exists in the Nordics. There is a lot Europe can learn from this region.

From Hormuz to the Western Pacific, the world’s most strategic waterways are becoming increasingly contested. Yet much of what happens at sea still happens out of sight. We’re backing Quartermaster through our partnership with @SteelAtlasVC to change that. Using commercial ships already on the water, Quartermaster is building a real-time intelligence layer for the ocean without launching satellites or deploying warships. When disruption in a single strait can move global trade and energy markets, knowing what is happening on the water becomes incredibly valuable. Proud to be backing the team as they build out the network, and help protect global trade.

I often post about @EliLillyandCo which, over the summer, agreed to pay up to $2.875 billion for Merida Biosciences, which is developing a new generation of precision medicines. Lilly has now committed more than $25 billion to acquisitions in 2026 alone. It is clearly building a pipeline for the next decade. Biotech investors holding differentiated assets that haven’t yet been repriced should take note. Deals like this show what big pharma is willing to pay for innovation.